Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Exchange Rate Effect (2022 - 2025)

Historic Exchange Rate Effect for Krystal Biotech (KRYS) over the last 4 years, with Q3 2025 value amounting to -$307000.0.

  • Krystal Biotech's Exchange Rate Effect fell 20734.27% to -$307000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $329000.0, marking a year-over-year increase of 832500.0%. This contributed to the annual value of -$458000.0 for FY2024, which is 19358.97% down from last year.
  • Latest data reveals that Krystal Biotech reported Exchange Rate Effect of -$307000.0 as of Q3 2025, which was down 20734.27% from $1.1 million recorded in Q2 2025.
  • Over the past 5 years, Krystal Biotech's Exchange Rate Effect peaked at $1.1 million during Q2 2025, and registered a low of -$594000.0 during Q4 2024.
  • Its 4-year average for Exchange Rate Effect is $22333.3, with a median of -$14000.0 in 2023.
  • Within the past 5 years, the most significant YoY rise in Krystal Biotech's Exchange Rate Effect was 228333.33% (2024), while the steepest drop was 431250.0% (2024).
  • Over the past 4 years, Krystal Biotech's Exchange Rate Effect (Quarter) stood at -$41000.0 in 2022, then tumbled by 241.46% to -$140000.0 in 2023, then tumbled by 324.29% to -$594000.0 in 2024, then surged by 48.32% to -$307000.0 in 2025.
  • Its Exchange Rate Effect stands at -$307000.0 for Q3 2025, versus $1.1 million for Q2 2025 and $171000.0 for Q1 2025.